I agree with you on the handling of MT's resignation.
but the loss of a patient is expected to be honest. what is more market sensitive is those who are still alive.
my point being that we expect to lose patients and to say that losing any is market sensitive is a fine line. it's normal and I'm not sure that losing a patient should cause people to run away from the share. actually, it shouldn't. if that drives selling, then we have shareholders with unrealistic expectations.
what we need right now is something from PAA to restore some confidence. i am pretty sure that the roadmap is unchanged but it would be a damn good piece of comms to come out and say it.
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-1257
-
- There are more pages in this discussion • 168 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $97.90M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 23.0¢ | 21.5¢ | $443.1K | 2.052M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 120200 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 22.0¢ | 124358 | 3 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| PAA (ASX) Chart |